Cy5.5 NHS Ester (Non-Sulfonated): Elevating Biomolecule Labeling and In Vivo Imaging Workflows

Principle Overview: Why Cy5.5 NHS Ester (Non-Sulfonated) Stands Out

Cy5.5 NHS ester (non-sulfonated) is a next-generation near-infrared fluorescent dye engineered for covalent labeling of biomolecules containing primary amines. With an excitation maximum at ~684 nm and emission near 710 nm, it offers high-contrast, low-background imaging ideal for both in vitro and in vivo studies. Unlike traditional visible-range dyes, its spectral profile enables deep-tissue penetration and minimal autofluorescence, making it the reagent of choice for applications such as optical imaging of tumors and advanced neuroscience workflows. The NHS ester group reacts rapidly and stably with lysine residues or N-termini, forming robust amide bonds that withstand rigorous downstream processing.

APExBIO supplies Cy5.5 NHS ester (non-sulfonated) as a solid, ensuring long-term stability (up to 24 months at -20°C, protected from light). Its high extinction coefficient (209,000 M⁻¹cm⁻¹) and quantum yield of 0.2 support sensitive, quantitative detection, while its solubility in DMSO (≥35.82 mg/mL) facilitates convenient preparation for conjugation protocols. For researchers seeking a fluorescent dye for protein conjugation or nanoparticle tracking, this reagent checks all the boxes for efficiency, reproducibility, and versatility.

Step-by-Step Workflow: From Dissolution to Covalent Labeling

Deploying Cy5.5 NHS ester (non-sulfonated) in your workflow involves several critical steps designed to maximize labeling efficiency and preserve biomolecule function. Below, we outline a robust protocol tailored for proteins, peptides, and functionalized nanoparticles.

Protocol Parameters

• Dye Dissolution: Dissolve Cy5.5 NHS ester (non-sulfonated) in DMSO or DMF at 5–10 mg/mL immediately before use. Protect from light and use within 1 hour to prevent hydrolysis (product information).
• Conjugation Reaction: Add the dye solution to biomolecule (protein, peptide, nanoparticle) in 0.1 M sodium phosphate buffer, pH 7.5–8.5, at a dye:protein molar ratio of 3:1 to 10:1. Incubate for 30–60 minutes at room temperature with gentle mixing.
• Purification: Remove excess dye by gel filtration (Sephadex G-25) or centrifugal filtration (10 kDa MWCO) at 4°C; elute labeled product in PBS or suitable buffer for downstream application.

Researchers working with more challenging targets, such as oligonucleotides or nanoparticles, should empirically optimize the dye:biomolecule ratio and buffer system, as steric accessibility and surface chemistry can affect conjugation yields (see advanced optimization tips).

Advanced Applications: Beyond Standard Biomolecule Labeling

The power of Cy5.5 NHS ester (non-sulfonated) shines in cutting-edge applications where sensitivity, specificity, and multiplexing are paramount. In particular, it has become a cornerstone for in vivo fluorescence imaging and near-infrared fluorescence imaging platforms:

• Optical Imaging of Tumors: Its deep-tissue penetration and low background enable detection of small lesions in preclinical cancer models. Conjugation to antibodies or peptides allows for tumor-specific imaging—demonstrated in benchmark studies.
• Blood-Brain Barrier (BBB) Crossing Nanoparticles: In the reference study, Cy5.5 NHS ester-labeled MOF nanoparticles allowed real-time tracking of nanoparticle transport across the BBB and into epileptic foci, supporting non-invasive neuromodulation workflows.
• Multiplexed Cellular Assays: The far-red/near-infrared emission spectrum permits use alongside blue/green/yellow labels, enabling simultaneous multi-target imaging in complex biological samples.

Compared to more hydrophilic (sulfonated) Cy5.5 derivatives, the non-sulfonated NHS ester offers superior membrane permeability and compatibility with organic-phase reactions, enhancing its utility for labeling hydrophobic nanoparticles or membrane proteins (complementary article).

Key Innovation from the Reference Study

The recent MOF-based nanoparticle study represents a significant leap in translational neuroscience. By using Cy5.5 NHS ester (non-sulfonated) to label piezoelectric, ligand-functionalized nanoparticles, the researchers achieved real-time, non-invasive tracking of nanoparticle delivery across the blood-brain barrier in a mouse epilepsy model. This enabled precise localization of nanoparticles in epileptic foci, validated by near-infrared in vivo imaging, and correlated with enhanced neuromodulatory effects under ultrasound stimulation.

For assay development, this approach demonstrates the critical importance of selecting dyes with deep-tissue penetration and minimal off-target binding. The success of their workflow suggests that researchers targeting hard-to-access tissues (e.g., brain, deep tumors) should prioritize near-infrared dyes like Cy5.5 NHS ester (non-sulfonated) for both diagnostic and therapeutic nanoparticle tracking. The study also highlights the value of rapid purification and immediate use of dye solutions to prevent signal loss due to hydrolysis or photobleaching.

Troubleshooting & Optimization Tips

• Low Labeling Efficiency: Confirm that the dye is fully dissolved in DMSO or DMF before addition. Increase the dye:protein ratio up to 10:1 or raise the pH slightly (up to 8.5) to enhance reactivity. Ensure that all buffers are amine-free (avoid Tris, glycine, or ammonium-containing buffers).
• High Background or Aggregation: Remove unreacted dye thoroughly by gel filtration or repeated spin filtration. For nanoparticles, add a BSA blocking step post-labeling to minimize non-specific binding.
• Signal Instability: Protect all solutions and labeled products from prolonged light exposure. Prepare dye solutions fresh and use within 1 hour; do not freeze dye solutions for later use, as per APExBIO's product guidance.
• Batch-to-Batch Variability: Standardize all workflow parameters, including incubation time, temperature (preferably room temp, ~22–25°C), and purification method. Validate each batch using absorbance at 684 nm and emission at 710 nm to normalize for dye incorporation.

Comparative Advantages: Why Choose APExBIO’s Cy5.5 NHS Ester (Non-Sulfonated)?

The competitive edge of APExBIO's Cy5.5 NHS ester (non-sulfonated) lies in its combination of optical performance, chemical stability, and workflow flexibility. Compared to conventional Cy5 or Alexa dyes, its higher extinction coefficient and emission in the near-infrared region drive superior sensitivity for deep-tissue imaging (comparative analysis). Its non-sulfonated structure broadens its compatibility with hydrophobic surfaces and nanoparticle systems, as leveraged in the reference study for epilepsy nanomedicine.

Recent thought-leadership articles emphasize that Cy5.5 NHS ester plays a pivotal role in accelerating translational imaging, offering high-contrast, non-destructive tracking of therapeutic agents in preclinical models. For researchers needing amino group labeling reagents that perform reliably across disparate platforms, this product delivers unmatched versatility and reproducibility.

Future Outlook: Expanding the Frontiers of Non-Invasive Imaging

The integration of Cy5.5 NHS ester (non-sulfonated) into advanced nanoparticle and protein labeling workflows signals a paradigm shift for non-invasive imaging and targeted therapy. As demonstrated in the reference study, the synergy of near-infrared tracking and functional nanomaterials unlocks new dimensions in precision neuromodulation and epilepsy therapy. These findings reinforce the growing consensus—reflected in recent reviews and mechanistic applications—that high-performance fluorescent dyes are critical enabling tools for next-generation translational research.

In the coming years, expect APExBIO's Cy5.5 NHS ester (non-sulfonated) to remain at the forefront of sensitive in vivo imaging, especially as the demand for multiplexed, deep-tissue, and longitudinal tracking intensifies. Researchers are encouraged to adopt best practices in conjugation and detection to fully leverage the reagent’s potential for both basic and clinical research pipelines.

Explore and Order

Ready to elevate your imaging and labeling workflows? Discover detailed specifications and order Cy5.5 NHS ester (non-sulfonated) directly from APExBIO, the trusted supplier for high-performance biochemical reagents. Harness its full power for your next breakthrough in optical imaging or molecular neuroscience research.